- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02898389
Influence of Chronic Vascular Diseases on Transcranial Doppler Profiles in Critically Ill Patients (CritiDop)
August 11, 2020 updated by: Centre Hospitalier Universitaire de Nīmes
The primary objective of this study is to show that cardiovascular risk factors associated with the chronic elevation of arterial resistance may be associated with "false" profiles of intracranial hypertension during transcranial doppler ultrasound of the middle cerebral arteries in intensive care unit patients.
A "false" profile of intracranial hypertension is defined by a high pulsatility index without any intracranial pathology.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
91
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nîmes Cedex 09, France, 30029
- CHU de Nimes - Hopital Universitaire Caremeau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All sedated patients under mechanical respiratory assistance will be included.
These are further devided into 2 groups.
Description
Inclusion Criteria for entry in the study:
- Sedated patient under mechanical respiratory assistance
Inclusion criteria for entry in group 1: the patient meets at least one of the following criteria:
- The patient is a man over the age of 50 or a woman over the age of 60
- Hypercholesterolemia (LDL > 1.6 g/L, HDL < 0.4 g/L)
- Arterial hypertension for over 10 years (treated or systolic arterial pressure > 140 mmHG)
- Type 2 diabetes for over 10 years
- Active or former smoker in the past 3 years
- History of cardiovascular event (peripheral artery disease, heart attack, stroke/transient ischemic attack over 3 months ago)
- Chronic renal insufficiency with MDRD < 30 ml/min/1.73m^2
Inclusion criteria for entry in group 2:
- The included patient is not in group 1
Exclusion Criteria:
- acute neurological disorder (brain trauma, infectious or immune meningitis, meningoencephalitis, ischemic or hemorrhagic stroke <3 months)
- pregnant woman
- person under guardianship
- prisoners
- recent carotid surgery (<1 month)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Group 1: With cardiovascular risk factors
Patients fall within this group when they have at least one of the cardiovascular risk factors listed in the eligibility criteria section.
|
Group 1: Without cardiovascular risk factors
Patients fall into this group when they do not have any of the cardiovascular risk factors listed in the eligibility criteria section.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pulsatility index on the middle cerebral arteries
Time Frame: Day 0
|
Day 0
|
Diastolic velocity at the middle cerebral arteries
Time Frame: Day 0
|
Day 0
|
Mean velocity at the middle cerebral arteries
Time Frame: Day 0
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Laurent Muller, MD, PhD, Centre Hospitalier Universitaire de Nîmes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 14, 2016
Primary Completion (Actual)
September 14, 2018
Study Completion (Actual)
September 14, 2018
Study Registration Dates
First Submitted
September 8, 2016
First Submitted That Met QC Criteria
September 8, 2016
First Posted (Estimate)
September 13, 2016
Study Record Updates
Last Update Posted (Actual)
August 12, 2020
Last Update Submitted That Met QC Criteria
August 11, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAL/2015/LM-01b
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiration, Artificial
-
Sanatorio Anchorena San MartinJavier Hernán Dorado; Joaquin PerezRecruitingRespiration, ArtificialArgentina
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Respinor ASEuropean CommissionCompletedRespiration, ArtificialNorway
-
Centre Hospitalier Universitaire, AmiensUnknownRespiration, ArtificialFrance
-
Lawson Health Research InstituteCompletedRespiration, ArtificialCanada
-
Children's Hospital of PhiladelphiaLaerdal MedicalCompleted
-
Children's Hospital of PhiladelphiaLaerdal MedicalCompletedRespiration, ArtificialUnited States
-
Medical University InnsbruckCompletedPositive-Pressure Respiration | Respiration; ArtificialAustria
-
Respinor ASEuropean CommissionCompletedRespiration, ArtificialFrance
-
Università degli Studi di FerraraAalborg UniversityCompletedArtificial RespirationItaly